-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics FY2029 Revenue expected to be more than

Benzinga·02/25/2026 21:15:28
Listen to the news
ADMA Biologics (NASDAQ:ADMA) FY2029 Revenue expected to be more than .